Annexon, Inc. Files 8-K: Board and Executive Compensation Changes
Ticker: ANNX · Form: 8-K · Filed: Jan 10, 2025 · CIK: 1528115
Sentiment: neutral
Topics: corporate-governance, executive-compensation, filing-update
TL;DR
Annexon's 8-K shows board shakeup and exec pay changes. Watch for strategic shifts.
AI Summary
On January 10, 2025, Annexon, Inc. filed an 8-K report detailing changes in its board of directors and executive compensation arrangements. The filing includes information regarding the departure of certain officers and the election of new directors, alongside updates to compensatory plans for key personnel.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy, governance, or financial priorities, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Changes in leadership and compensation can indicate internal shifts that may affect the company's future direction and performance.
Key Players & Entities
- Annexon, Inc. (company) — Registrant
- January 10, 2025 (date) — Date of earliest event reported
FAQ
What specific items are covered in Annexon, Inc.'s January 10, 2025 8-K filing?
The filing covers the departure of directors or certain officers, election of directors, appointment of certain officers, compensatory arrangements of certain officers, Regulation FD Disclosure, and Financial Statements and Exhibits.
What is Annexon, Inc.'s state of incorporation and fiscal year end?
Annexon, Inc. is incorporated in Delaware and its fiscal year ends on December 31.
What is the business address and phone number for Annexon, Inc.?
The business address is 1400 Sierra Point Parkway, Bldg C, Suite 200, Brisbane, California 94005, and the phone number is (650) 822-5500.
What is Annexon, Inc.'s SIC code?
Annexon, Inc.'s Standard Industrial Classification (SIC) code is 2834, which corresponds to Pharmaceutical Preparations.
What is the SEC file number and film number for this Annexon, Inc. 8-K filing?
The SEC file number is 001-39402 and the film number is 25520539.
Filing Stats: 821 words · 3 min read · ~3 pages · Grade level 10.8 · Accepted 2025-01-10 08:13:47
Key Financial Figures
- $0.001 — ich registered Common Stock, par value $0.001 per share ANNX The Nasdaq Stock Mar
- $40,000 — director, Mr. Jones will receive (i) a $40,000 annual retainer for his service on the
Filing Documents
- d796195d8k.htm (8-K) — 28KB
- d796195dex991.htm (EX-99.1) — 10KB
- g796195dsp5.jpg (GRAPHIC) — 4KB
- 0001193125-25-004133.txt ( ) — 172KB
- annx-20250110.xsd (EX-101.SCH) — 3KB
- annx-20250110_lab.xml (EX-101.LAB) — 18KB
- annx-20250110_pre.xml (EX-101.PRE) — 11KB
- d796195d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release, dated January 10, 2025. 104.1 Cover Page Interactive Data File, formatted in inline XBRL.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: January 10, 2025 Annexon, Inc. By: /s/ Jennifer Lew Jennifer Lew Executive Vice President and Chief Financial Officer